Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
Esophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint in...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/120ec580cf31457798702ef13132b2c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:120ec580cf31457798702ef13132b2c7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:120ec580cf31457798702ef13132b2c72021-11-22T06:09:58ZNovel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer2296-634X10.3389/fcell.2021.764313https://doaj.org/article/120ec580cf31457798702ef13132b2c72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.764313/fullhttps://doaj.org/toc/2296-634XEsophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint inhibitors improved the prognosis in a portion of patients with advanced esophageal cancer. Unfortunately, a number of esophageal cancer patients develop drug resistance, resulting in poor outcomes. Multiple mechanisms contributing to drug resistance of esophageal cancer have been reported. Notably, non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have been identified to play crucial roles in modulating esophageal cancer drug resistance. In the present review, we highlight the underlying mechanisms how miRNAs, lncRNAs, and circRNAs impact the drug resistance of esophageal cancer. Several miRNAs, lncRNAs, and circRNAs may have potential clinical implications as novel biomarkers and therapeutic targets for esophageal cancer.Ling WeiJujie SunNasha ZhangYue ShenTeng WangZengjun LiMing YangFrontiers Media S.A.articleesophageal cancerdrug resistancemicroRNAlong non-coding RNAcircular RNABiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
esophageal cancer drug resistance microRNA long non-coding RNA circular RNA Biology (General) QH301-705.5 |
spellingShingle |
esophageal cancer drug resistance microRNA long non-coding RNA circular RNA Biology (General) QH301-705.5 Ling Wei Jujie Sun Nasha Zhang Yue Shen Teng Wang Zengjun Li Ming Yang Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
description |
Esophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint inhibitors improved the prognosis in a portion of patients with advanced esophageal cancer. Unfortunately, a number of esophageal cancer patients develop drug resistance, resulting in poor outcomes. Multiple mechanisms contributing to drug resistance of esophageal cancer have been reported. Notably, non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have been identified to play crucial roles in modulating esophageal cancer drug resistance. In the present review, we highlight the underlying mechanisms how miRNAs, lncRNAs, and circRNAs impact the drug resistance of esophageal cancer. Several miRNAs, lncRNAs, and circRNAs may have potential clinical implications as novel biomarkers and therapeutic targets for esophageal cancer. |
format |
article |
author |
Ling Wei Jujie Sun Nasha Zhang Yue Shen Teng Wang Zengjun Li Ming Yang |
author_facet |
Ling Wei Jujie Sun Nasha Zhang Yue Shen Teng Wang Zengjun Li Ming Yang |
author_sort |
Ling Wei |
title |
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
title_short |
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
title_full |
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
title_fullStr |
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
title_full_unstemmed |
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer |
title_sort |
novel implications of micrornas, long non-coding rnas and circular rnas in drug resistance of esophageal cancer |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/120ec580cf31457798702ef13132b2c7 |
work_keys_str_mv |
AT lingwei novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT jujiesun novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT nashazhang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT yueshen novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT tengwang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT zengjunli novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer AT mingyang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer |
_version_ |
1718418085926404096 |